文献速递肿瘤 PET/CT放射性药物与辐射防护

hHEPATO-Cy5:用于影像引导肝胆手术的双模态示踪剂

hHEPATO-Cy5, a Bimodal Tracer for Image-Guided Hepatobiliary Surgery.
PubMed 文献 · J Nucl Med · 2024-08-01

研究合成并表征了结合甲基化Cy5荧光染料与巯基乙酰三丝氨酸螯合物的双模态示踪剂hHEPATO-Cy5,在肝细胞培养中评估其摄取与排泄,在小鼠中评估99mTc-hHEPATO-Cy5的药代动力学与SPECT/CT及荧光成像,并在猪模型中与ICG对照评估机器人辅助肝胆手术中的实时荧光引导能力。结果显示hHEPATO-Cy5促进肝胆排泄,小鼠胆囊计数率随时间下降两个数量级(P=0.008),猪模型中荧光识别病灶与ICG相当。

要点

  • hHEPATO-Cy5在肝细胞中10分钟内快速清除,而甲基化Cy5保持内化。
  • 小鼠中99mTc-hHEPATO-Cy5表现为肝脏蓄积和快速胆道清除。
  • 猪模型中hHEPATO-Cy5荧光识别病灶与ICG相当。

核心结论

  • 双模态99mTc-hHEPATO-Cy5为识别肝脏病灶提供了有效手段,并通过深度放射性引导克服了仅荧光方法的不足。

研究设计与样本

  • 合成并表征由甲基化Cy5荧光染料和巯基乙酰三丝氨酸螯合物组成的示踪剂hHEPATO-Cy5。
  • 在肝细胞培养(二维培养和体外病灶模型)中评估细胞摄取与排泄,使用荧光胆盐、MitoTracker染料和甲基化Cy5作为对照。
  • 放射性标记后在小鼠中评估99mTc-hHEPATO-Cy5的24小时药代动力学(注射剂量百分比和每克组织注射剂量百分比、SPECT/CT成像和荧光成像)。
  • 在猪模型中以ICG为参照评估机器人辅助肝胆手术中实时荧光引导的能力。

主要发现

  • hHEPATO-Cy5的独特分子特征促进肝胆排泄。
  • 肝细胞体外研究中,甲基化Cy5保持内化,而hHEPATO-Cy5显示快速清除(10分钟),与荧光胆盐相似。
  • 小鼠体内使用99mTc-hHEPATO-Cy5显示肝脏蓄积和快速胆道清除。
  • 胆囊计数率随时间下降两个数量级(P=0.008),最佳体现了胆汁清除效果。
  • 猪模型肝胆手术中,hHEPATO-Cy5实现的荧光病灶识别与ICG相当。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Liver cancer is a leading cause of cancer deaths worldwide. Surgical resection of superficial hepatic lesions is increasingly guided by the disrupted bile excretion of the fluorescent dye indocyanine green (ICG). To extend this approach to deeper lesions, a dedicated bimodal tracer that facilitates both fluorescence guidance and radioguidance was developed. Methods: A tracer comprising a methylated cyanine-5 (Cy5) fluorescent dye and a mercaptoacetyltriserine chelate (hHEPATO-Cy5) was synthesized and characterized. Cellular uptake and excretion were evaluated in hepatocyte cultures (2-dimensional culture and in vitro lesion model), using a fluorescent bile salt, MitoTracker dye, and methylated Cy5 as a control. After radiolabeling, the pharmacokinetics of 99mTc-hHEPATO-Cy5 were assessed in mice over 24 h (percentage injected dose and percentage injected dose per gram of tissue, SPECT/CT imaging and fluorescence imaging). The ability to provide real-time fluorescence guidance during robot-assisted hepatobiliary surgery was evaluated in a porcine model using ICG as a reference. Results: The unique molecular signature of hHEPATO-Cy5 promotes hepatobiliary excretion. In vitro studies on hepatocytes showed that where methylated Cy5 remained internalized, hHEPATO-Cy5 showed fast clearance (10 min) similar to that of fluorescent bile salt. In vivo use of 99mTc-hHEPATO-Cy5 in mice revealed liver accumulation and rapid biliary clearance. The effectiveness of bile clearance was best exemplified by the 2-orders-of-magnitude reduction in count rate for the gallbladder (P = 0.008) over time. During hepatobiliary surgery in a porcine model, hHEPATO-Cy5 enabled fluorescence-based lesion identification comparable to that of ICG. Conclusion: The bimodal 99mTc-hHEPATO-Cy5 provides an effective means to identify liver lesions. Uniquely, it helps overcome the shortcomings of fluorescence-only approaches by allowing for an extension to in-depth radioguidance.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Rietbergen DDD, Buckle T, Slof LJ, et al. hHEPATO-Cy5, a Bimodal Tracer for Image-Guided Hepatobiliary Surgery. J Nucl Med. 2024. PMID: 39025649. doi:10.2967/jnumed.123.266715

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。